Biotech innovator Bugworks Research which addresses anti-microbial resistance, secures funding from the Defense Threat Reduction Agency (DTRA) to support development of its novel broad-spectrum antibiotic BWC0977, against the most critical bacterial biothreats. Bugworks was set up in 2014 and incubated at the Centre for Cellular And Molecular Platforms, Bangalore. The...